EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   2.4.1.149 | Lung Neoplasms |
14706853 |
beta1,3-N-Acetylglucosaminyltransferase-7 (beta3Gn-T7) acts efficiently on keratan sulfate-related glycans. |
therapeutic application
unassigned |
1
0 |
| 2.4.1.149 | Neoplasms |
19587235 |
Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. |
unassigned |
0 |
| 2.4.1.149 | Prostatic Neoplasms |
23359570 |
Missense mutations in ?-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. |
ongoing research
unassigned |
2
0 |
| 2.4.1.149 | Walker-Warburg Syndrome |
23877401 |
A truncating mutation in B3GNT1 causes severe Walker-Warburg syndrome. |
causal interaction
unassigned |
4
0 |
| 2.4.1.149 | Neoplasms |
24118321 |
B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
4
1
0 |
| 2.4.1.149 | Neuroblastoma |
24118321 |
B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
4
1
0 |
| 2.4.1.149 | Muscular Dystrophies |
25279697 |
B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of ?-dystroglycan. |
unassigned |
0 |
| 2.4.1.149 | Muscular Dystrophies |
25353622 |
Integrative data mining highlights candidate genes for monogenic myopathies. |
unassigned |
0 |
| 2.4.1.149 | Infections |
26709519 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
| 2.4.1.149 | Lymphatic Metastasis |
26709519 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
